US EditionPublished • loading... • Updated
US Approves First GLP-1 Pill for Weight Loss: Novo Nordisk
Summary by The Straits Times
3 Articles
3 Articles
A decision applauded by the U.S. network Obesity Care Advocacy Network. U.S. health authorities approved on Monday a first tablet version of the flagship anti-obesity treatment Wegovy, offering Americans a first alternative to injections to lose weight, announced the Danish pharmaceutical laboratory Novo Nordisk which markets it.This green light should make it easier to access these weight loss treatments already very popular and considered by m…
·Paris, France
Read Full Article
The US Drug Agency (FDA) has approved a first tablet version of a flagship anti-obesity treatment.
·Montreal, Canada
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left1Leaning Right2Center0Last UpdatedBias Distribution67% Right
Bias Distribution
- 67% of the sources lean Right
67% Right
L 33%
R 67%
Factuality
To view factuality data please Upgrade to Premium
